European Journal of Internal Medicine
Volume 20, Issue 4 , Pages 348-354, July 2009

Vascular disease in rheumatoid arthritis: From subclinical lesions to cardiovascular risk

  • Coman Tanasescu

      Affiliations

    • Department of Internal Medicine, Colentina Clinical Hospital, Bucharest, Romania
    • University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania
    • Corresponding Author InformationCorresponding author. Department of Internal Medicine, Colentina Hospital, Soseaua Stefan cel Mare 19-21, sect. 2, 020125 Bucharest, Romania. Tel./fax: +40 212107326.
  • ,
  • Ciprian Jurcut

      Affiliations

    • 3rd Internal Medicine Department, “Carol Davila” Central Clinical Emergency Military Hospital, Bucharest, Romania
  • ,
  • Ruxandra Jurcut

      Affiliations

    • Department of Cardiology, “Prof. Dr. C. C. Iliescu” Institute of Cardiovascular Diseases, Bucharest, Romania
    • University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania
  • ,
  • Carmen Ginghina

      Affiliations

    • Department of Cardiology, “Prof. Dr. C. C. Iliescu” Institute of Cardiovascular Diseases, Bucharest, Romania
    • University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania

Received 13 March 2008; received in revised form 31 July 2008; accepted 4 September 2008. published online 21 October 2008.

Abstract 

Rheumatoid arthritis (RA) is one of the most prevalent and complex inflammatory diseases affecting primarily the joints, but also associating several extra-articular features. The vascular disease in RA encompasses a large spectrum of lesions, from rheumatoid vasculitis to atherosclerotic lesions. During the last years the importance of the vascular disease related to atherosclerosis in terms of cardiovascular morbidity and global mortality became evident in RA. The inflammatory hypothesis of atherosclerosis in RA implies that mediators originating from the inflamed synovial tissue or from the liver may have systemic vascular consequences, leading to endothelial dysfunction and structural abnormalities of the vessels. Hence, the global management of patients with RA must include the improvement of cardiovascular risk in parallel with the management of joint disease.

Keywords: Rheumatoid arthritis, Cardiovascular disease, Endothelial dysfunction, Vascular stiffness, Statins

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0953-6205(08)00263-X

doi:10.1016/j.ejim.2008.09.005

European Journal of Internal Medicine
Volume 20, Issue 4 , Pages 348-354, July 2009